Paksoy provides advice across a broad spectrum of areas including pharmaceuticals, biotechnology, medical devices, nutritional supplements, clinical research and private hospitals.
We assist our clients on a wide range of issues concerning the healthcare and pharmaceuticals sector. We provide guidance from product inception to final marketing and commercialisation of products in Turkey.
We also support our clients in drafting contracts regarding manufacturing and distribution of medical devices and medicinal products, devising and implementing compliance programs, in particular with regard to the promotion, transparency rules and public procurement legislation.
We also have substantial experience of the issues affecting healthcare and pharmaceuticals companies in the context of M&A transactions.
“ Paksoy is one of the few Turkish firms to gain recognition in this specialist area. ”
PLC Which Lawyer
Featured publications
27 October 2020
Manufacturing of medicinal products for human use in Turkey
Our latest article "Manufacturing of medicinal products for human use in Turkey" is published on Lexology.
Related contents
12 January 2024
Amendment on Applications for Scientific Meetings and Educational Activites
The Guideline on Scientific Meetings and Educational Activities to be Held Within the Scope of the Regulation on Sale, Advertisement and…
29 December 2023
Co-Marketing of Medicinal Products in Türkiye
Co-marketing is a tool that allows sale of medicinal products with the same qualitative and quantitative composition and in the same…
2 November 2023
Recent developments in Healthcare Legislation – 2023 Summer/Fall Issue
We would like to share with you our information note where we have summarised the latest developments in the healthcare legislation…
12 May 2023
Recent Developments in Healthcare Legislation – May 2023
We would like to share with you a summary of the recent changes and developments in the healthcare legislation.
31 January 2023
Recent Amendments to the Private Hospitals Regulation
Certain changes have been made in October 2022 and January 2023 on the Private Hospitals Regulation.
18 January 2023
Pharmacovigilance Obligations of Marketing Authorisation Holders
Our latest article is published on Mondaq.